Acotec Scientific Holdings Limited (HKG:6669)
Hong Kong · Delayed Price · Currency is HKD 5.81
+0.05 (0.78%)
Sep 11, 2026, 3:59 PM HKT
HKG:6669 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 625 | 644.63 | 533.99 | 473.85 | 395.55 | 303.81 | |
Revenue Growth | 5.42% | 20.72% | 12.69% | 19.80% | 30.19% | 56.63% |
Cost of Revenue | 176.01 | 168.32 | 131.27 | 96.43 | 59.19 | 37.87 |
Gross Profit | 448.99 | 476.31 | 402.72 | 377.42 | 336.35 | 265.94 |
Selling, General & Admin | 162.05 | 182.33 | 157.71 | 181.32 | 160.51 | 116.89 |
Research & Development | 350.67 | 213.67 | 216.77 | 190.07 | 183.8 | 141.29 |
Other Operating Expenses | -25.67 | -25.5 | -7.69 | -16.92 | -7.1 | - |
Operating Expenses | 487.05 | 370.5 | 366.67 | 354.29 | 337.31 | 257.37 |
Operating Income | -38.06 | 105.81 | 36.05 | 23.13 | -0.96 | 8.57 |
Interest Expense | -9.42 | -9.39 | -9.9 | -9.83 | -1.42 | -3.82 |
Interest & Investment Income | 22.43 | 25.67 | 30.15 | 18.51 | 20.26 | 4.73 |
Earnings From Equity Investments | -0.41 | -0.7 | 0.1 | -0.6 | - | - |
Currency Exchange Gain (Loss) | -24.12 | -13.25 | 1.5 | -13.7 | 52.97 | -8.79 |
Other Non Operating Income (Expenses) | -0.83 | -0.89 | -1.61 | -0.13 | -0.34 | 6.69 |
EBT Excluding Unusual Items | -50.4 | 107.25 | 56.29 | 17.37 | 70.52 | 7.38 |
Gain (Loss) on Sale of Investments | 0.96 | 15.83 | 2.92 | -2.77 | -0.19 | -33.4 |
Gain (Loss) on Sale of Assets | -1.01 | -0.9 | -6.61 | -0.15 | -0.01 | -0.1 |
Other Unusual Items | 2.57 | - | - | - | - | -41.13 |
Pretax Income | -47.88 | 122.18 | 52.6 | 14.45 | 70.32 | -67.24 |
Income Tax Expense | 2.35 | 3 | 0.32 | -0.04 | 0.18 | 11.83 |
Earnings From Continuing Operations | -50.23 | 119.18 | 52.28 | 14.49 | 70.14 | -79.08 |
Net Income | -50.23 | 119.18 | 52.28 | 14.49 | 70.14 | -79.08 |
Net Income to Common | -50.23 | 119.18 | 52.28 | 14.49 | 70.14 | -79.08 |
Net Income Growth | - | 127.97% | 260.88% | -79.35% | - | - |
Shares Outstanding (Basic) | 302 | 302 | 301 | 301 | 300 | 248 |
Shares Outstanding (Diluted) | 302 | 302 | 301 | 301 | 300 | 248 |
Shares Change | 0.26% | 0.23% | 0.06% | 0.49% | 20.78% | 33.16% |
EPS (Basic) | -0.17 | 0.40 | 0.17 | 0.05 | 0.23 | -0.32 |
EPS (Diluted) | -0.17 | 0.39 | 0.17 | 0.05 | 0.23 | -0.32 |
EPS Growth | - | 129.41% | 253.30% | -79.08% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 127.83 | 50.73 | -92.48 | -112.17 | -30.84 |
Free Cash Flow Per Share | - | 0.42 | 0.17 | -0.31 | -0.37 | -0.12 |
Gross Margin | 71.84% | 73.89% | 75.42% | 79.65% | 85.04% | 87.53% |
Operating Margin | -6.09% | 16.41% | 6.75% | 4.88% | -0.24% | 2.82% |
Profit Margin | -8.04% | 18.49% | 9.79% | 3.06% | 17.73% | -26.03% |
Free Cash Flow Margin | - | 19.83% | 9.50% | -19.52% | -28.36% | -10.15% |
EBITDA | -14.89 | 129.65 | 55.47 | 38.43 | 8.65 | 14.21 |
EBITDA Margin | -2.38% | 20.11% | 10.39% | 8.11% | 2.19% | 4.68% |
D&A For EBITDA | 23.17 | 23.84 | 19.42 | 15.3 | 9.6 | 5.64 |
EBIT | -38.06 | 105.81 | 36.05 | 23.13 | -0.96 | 8.57 |
EBIT Margin | -6.09% | 16.41% | 6.75% | 4.88% | -0.24% | 2.82% |
Effective Tax Rate | - | 2.45% | 0.61% | - | 0.25% | - |